ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 186 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $713,000 | -70.0% | 57,340 | -66.9% | 0.00% | -72.7% |
| Q3 2016 | $2,375,000 | +290.0% | 173,410 | +110.5% | 0.01% | +266.7% |
| Q2 2016 | $609,000 | -0.3% | 82,366 | -21.3% | 0.00% | -25.0% |
| Q3 2015 | $611,000 | -68.7% | 104,652 | -55.7% | 0.00% | -66.7% |
| Q2 2015 | $1,952,000 | +39.9% | 236,101 | +39.4% | 0.01% | +9.1% |
| Q1 2015 | $1,395,000 | +103.6% | 169,368 | +69.7% | 0.01% | +83.3% |
| Q4 2014 | $685,000 | +341.9% | 99,800 | +311.4% | 0.01% | +200.0% |
| Q2 2014 | $155,000 | -83.3% | 24,259 | -79.0% | 0.00% | -80.0% |
| Q1 2014 | $930,000 | – | 115,442 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |